Scientists from the University of South Australia (UniSA), along with colleagues from Third Military Medical University in Chongqing, China, have discovered the drug Edaravone can alleviate the progressive cognitive deficits of Alzheimer’s disease, a major social and economic burden worldwide.

Edaravone is currently available only in some Asian countries for the treatment of ischemic stroke — the most common type of stroke which is caused by blood clots.

Lead researcher Professor Xin-Fu Zhou, who is UniSA’s Research Chair in Neurosciences, says Edaravone can alleviate Alzheimer’s Disease pathologies and improve functions of learning and memory — in a mouse model of the disease – by multiple mechanisms.

READ FULL ARTICLE Curated publisher From Medical Express